David N. Standring
Plus aucun poste en cours
Historique de carrière de David N. Standring
Anciens postes connus de David N. Standring
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IDENIX PHARMACEUTICALS INC | Directeur Technique/Scientifique/R&D | 28/02/2011 | 09/09/2013 |
| Corporate Officer/Principal | 01/09/2000 | 28/02/2011 | |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | 01/02/1998 | 01/07/2000 |
Formation de David N. Standring
| Harvard University | Doctorate Degree |
| University of Oxford | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Royaume-Uni | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
- Bourse
- Insiders
- David N. Standring
- Expérience
